Fidelity Advisor Biotechnology Fund - Class C (FBTCX) - Health fund with $2.85 Billion in assets. The fund allocates 56.86% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is ABBVIE INC at 16.58% of total assets. This is followed by AMGEN INC (2.58%) and Fidelity Securities Lending Cash Central Fund (4.31%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| ABBVIE INC | 16.58% | - | - |
| AMGEN INC | 2.58% | - | - |
| Fidelity Securities Lending Cash Central Fund | 4.31% | - | - |
| REGENERON PHARMACEUTICALS INC | 6.90% | - | - |
| VERTEX PHARMACEUTICALS INC | 5.07% | - | - |
| ALNYLAM PHARMACEUTICALS INC | 7.66% | - | - |
| ARGENX SE SPONSORED ADR | 4.69% | - | - |
| ASCENDIS PHARMA AS SPON ADR | 4.29% | - | - |
| VAXCYTE INC | 2.18% | - | - |
| CYTOKINETICS INC | 2.60% | - | - |
| Fidelity Cash Central Fund | 2.05% | - | - |
| GILEAD SCIENCES INC | 5.50% | - | - |
| INSMED INC | 3.93% | - | - |
| NUVALENT INC-A | 2.29% | - | - |
| VIRIDIAN THERAPEUTICS INC | 2.42% | - | - |
| UNIQURE N.V. | 2.70% | - | - |